Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
filingDate |
2010-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2013514090-A |
titleOfInvention |
Method for characterizing host immune function by ex vivo induction of aggressive and protective immune markers |
abstract |
Host immune function can be characterized by quantifying changes in markers associated with aggressive and protective immune functions. One method can be used to identify potentially effective therapies for a subject based on the induction of expression of aggressive and protective immune function related markers. In addition, some methods are used to identify drugs that stimulate either an aggressive or protective immune response, but that can inhibit the other of the aggressive or protective immune response. be able to. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370719-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015511702-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016540496-A |
priorityDate |
2009-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |